The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients;Ocena steżeń czynnika stymulujacego kolonie granulocytarne i granulocytarno-makrofagowe w osoczu chorych na raka piersi

Polski Merkuriusz Lekarski

Volumn 23, Issue 136, 2007, Pages 259-263

  Ławicki, Sławomir ^a   Czygier, Małgorzata ^a   Omyła, Jacek ^b   Bedkowska, Ewa ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Białostockie Centrum Onkologii   (Poland)

Author keywords

Breast cancer; Granulocyte colony stimulating factor (G CSF); Granulocyte macrophage colony stimulating factor (GM CSF); Tumor markers

Indexed keywords

CA 15-3 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 35948997676     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aharinejad S., Abraham D., Paulus P. i wsp.: Colony-stimulating factor-1 antisense treatment supresses growth of human tumor xenografts in mice. Cancer Res., 2002, 62, 5317-5324.
2. Asschert J.G.W., Vellenga E., Hollema H. i wsp.: Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1 β (IL-1 β), interlekin-11 (IL-11) and tumour necrosis factor-β (TNF-α) in p53-characterised human ovarian carcinomas. Eur. J. Cancer, 1997, 33, 2246-2251.
3. Bartucci M., Morelli C., Mauro L. i wsp.: Differential insulin-like growth factor 1 receptor signaling and function in estrogen receptor (ER) - positive MCF-7 and ER - negative MDA-MB-231 breast cancer. Cancer Res., 2001, 61, 6747-6754.
4. Czygier M., Ławicki S., Szmitkowski M. i wsp.: Steżenie wzrostowego czynnika granulopoezy (G-CSF) w osoczu i aktywność enzymów w granulocytach u chorych na raka piersi. Gin. Pol., 2004, 75, 2, 99-104.
5. Czygier M., Ławicki S., Szmitkowski M. iwsp.: Sieżenie osoczowego czynnika wzrostu kolonii granulocytarno-makrofagowych (GM-CSF) i aktywność enzymów w granulocytach u chorych na raka piersi. Przeglad Lek., 2004, 63, 8, 654-657.
6. Findeisen R., Albrecht S., Richter B. i wsp.: Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer. Luminescence, 2000, 15, 283-289.
7. Hines S.J., Litz J.S., Krystal G.W.: Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the family of growth factors. Breast Cancer Res. Treatm., 1999, 58, 1-7.
8. Hintzen R.Q., Voormolen J., Sonneveld P.: Glioblastoma causing granulocytosis by secretion of granulocyte - colony stimulating factor. Neurology, 2000, 54, 259-261.
9. Jager W., Eibner K., Loffler B. i wsp.: Serial CEA and CA 15-3 measurements during follow-up of breast cancer patients. Anticancer Res., 2000, 20, 5179-5182.
10. Kaciński B.M.: CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev., 1997, 46, 71-74.
11. Kim H.K., Song K.S., Kim H.O. i wsp.: Circulating numbers of endothelial progenitors cells in patients with gastric and breast cancer. Cancer Lett., 2003, 198, 83-88.
12. Kokko R., Holli K., Hakama M.: CA 15-3 in the follow-up of localised breast cancer: a prospective study. Eur. J. Cancer, 2002, 38, 1189-1193
13. Kumpulainen E.J., Keskikuru R.J., Johansson R.T.: Serum tumor marker CA 15-3 and stage are the two most powerful predictors of survival in primary breast cancer. Breast Cancer Research Treatment, 2002, 76, 95-99.
14. Lacroix M., Siwek B., Marie P.J. i wsp.: Production and regulation of interleukin 11 by breast cancer cells. Cancer Lett., 1998, 127, 29-34.
15. Lin E.Y., Gouon-Evans V., Nguyen V. i wsp.: The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland. Biol. Neoplasia, 2002, 7, 147-162.
16. Ławicki S., Mroczko B., Szmitkowski M.: Cytokiny hematopoetyczne jako markery chomby nowotworowej. Post. Hig. Med. Dośw., 2001, 55, 449-465.
17. Ławicki S., Mroczko B., Omyła J. i wsp.: Czynnik wzrostu kolonii makrofagowych (M-CSF) jako kandydat na markers nowotworowego raka piersi. Pol. Arch.. Med. Wew., 2003, 6, 595-600.
18. Ławicki S., Mroczko B., Szmitkowski M.: Cytokiny jako markery nowotworowe raka piersi. Post. Hig. Med. Dośw., 2003, 57, 455-463.
19. Ławicki S., Omyła J., Mroczko B. i wsp.: Steżem'e w osoczu czynnika wzrostu kolonii makrofagowych (M-CSF) w przebiegu leczenia raka piersi. Pol. Arch. Med. Wew., 2004, 4, 1181-1187.
20. Ławicki S., Szmitkowski M., Wojtukiewicz M.: The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients. Clin. Chim. Acta, 2006, 371, 112-116.
21. Ławicki S., Czygier M., Gacuta-Szumarska E. i wsp.: Steżenie i przydatność diagnostyczna czynnika stymulujacego kolonie granulocytarne (G-CSF) i makrofagowe (M-CSF) w osoczu chorych na raka jajnika. Pol. Merk. Lek., 2006, 21, 465-468.
22. Mancino A.T., Klimberg V.S., Yamamoto M. i wsp.: Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J. Surg. Res., 2001, 100, 18-24.
23. McDermott R.S., Deneux L., Mosseri V. i wsp.: Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur. Cytokine Network., 2002, 13, 121-127.
24. Mroczko B., Szmitkowski M., Okulczyk B.: Hematopoietic growth factors in colorectal cancer patients. Clin. Chem. Lab. Med., 2003, 41, 646-651.
25. Mroczko B., Szmitkowski M., Wereszczyńska-Siemiatkowska U. i wsp.: Hematopoietic cytokines in the sera of patients with pancreatic cancer. Clin. Chem. Lab. Med., 2005, 43, 146-150.
26. Olt G., Soper J., Ramakrishnan S. i wsp.: Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer. Am. J. Obstet. Gynecol., 1996, 174, 1316-1319.
27. Price J.T., Tiganis T., Agarwal A. i wsp.: Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3-kinase andphospholipase C-dependent mechanism. Cancer Res., 1999, 59, 5475-5478.
28. Sapi E., Flick M.B., Rodov S. i wsp.: Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor - stimulated invasion by BT20 breast carcinoma cells. Cancer Res., 1998, 58, 1027-1033.
29. Sasco A.: Epidemiology of breast cancer: an environmental disease? APMIS, 2001, 109, 321-332.
30. Sonobe H., Ohtsuki Y., Ido E. i wsp.: Epithelioid sarcoma producing granulocyte colony-stimulating factor. Hum. Pathol., 1997, 29, 1433-1435.
31. Szymandera J.J., Góźdź S.S.: Rola krażacych markerów nowotworowych w diagnostyce i monitorowaniu leczenia chorych na nowotwory. Nowotwory, 1995, 45, 369-383.
32. Tampellini M., Berruti A., Gorzegno G. i wsp.: Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. Tumor Biol., 2001, 22, 367-373.
33. Trutmann M., Terracciano L., Noppen C. i wsp.: GM-CSF gene expression and protein production in human colorectal cancer cell lines and Clinical tumor specimens. Int. J. Cancer, 1998, 77, 378-385.
34. Tsuge T., Yamakawa M., Tsukamoto M.: Infiltrating dendritic/Langerhans cells in primary breast cancer. Breast Cancer Res. Treat., 2000, 59, 141-148.
35. Yee D.L., Liu Li.: The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res., 2000, 20, 4379-4384.
36. Young M.R., Lozano Y, Coogan M.: Stimulation of the metastasis properties of Lewis-lung carcinoma cells by autologous granulocyte-macrophage - colony stimulating factor. Int. J. Cancer, 1992, 50, 628-634.
37. Zhang G-J., Adachi I.: Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res., 1999, 19, 1427-1432.